OncoSil Medical is an Australian medical device company that develops a targeted radiation treatment for people with pancreatic cancer. Its product is a radioactive implant placed directly into a pancreatic tumour through an endoscopic procedure, designed to deliver a local dose of radiation to the cancer while sparing surrounding healthy tissue. The company works with clinicians and hospitals that treat pancreatic cancer, and it is based in Australia.
The shares are listed on the Australian Securities Exchange in Australia under the code OSL, and the price on this page is in Australian dollars (AUD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #933 of 1816 on the Australian Securities Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for Australia yet.
TrendStrong
71/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average1.1%
From 52-week high-49.5%
MomentumWeak
46/100
Lagging most stocks on this exchange.
See the numbers →
3-month return-31.3%
6-month return54.9%
12-month, skipping last month-39.6%
Stability (higher is calmer)Weak
23/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)95.4%
Worst drawdown, 1 year (smaller is calmer)-74.0%
LiquidityFair
65/100
Moderate trading activity.
See the numbers →
Avg daily value traded0.15M AUD
Zero-volume days0.0%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for Australia when fundamentals data for this market is added. All Australia stocks.
52-wk range 0.370 – 1.710Daily closes, split-adjusted
Signals
50-day average0.948
200-day average0.781
Golden/death cross (60d)Golden, 59 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.047
Technical summary
Daily
Neutral
5 bullish · 4 neutral · 7 bearish
Weekly
Strongly bearish
0 bullish · 1 neutral · 11 bearish
Monthly
Strongly bearish
1 bullish · 1 neutral · 6 bearish
Moving averages (daily)
SMA 10
0.76
Bullish
EMA 10
0.78
Bullish
SMA 20
0.78
Bullish
EMA 20
0.80
Bearish
SMA 50
0.95
Bearish
EMA 50
0.89
Bearish
SMA 100
0.97
Bearish
EMA 100
0.90
Bearish
SMA 200
0.78
Bullish
EMA 200
0.94
Bearish
Oscillators (daily)
RSI (14)
44.26
Neutral
MACD (12, 26)
-0.04
Bearish
Momentum (12)
5.33
Bullish
Stochastic %K (14)
74.19
Neutral
Williams %R (14)
-25.81
Neutral
CCI (20)
11.00
Neutral
Pivot points (classic, last session)
S3
0.74
S2
0.75
S1
0.77
Pivot
0.79
R1
0.81
R2
0.82
R3
0.84
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in AUD. Educational only, not financial advice.
